Om Xellia Pharmaceuticals

Xellia is a leading manufacturer of active pharmaceutical ingredients (APIs), specialized in fermented antibiotics and injectable finished products. Our ambition is to take a leading role in providing high quality products and solutions to the pharmaceutical industry. We believe that partnership is the most effective way to constantly improve and bring both our customers’ and our own business forward. 

In April 2008, investment funds managed by the private equity firm 3i and members of the management team acquired Xellia from Alpharma Inc. This means a new beginning for our well-reputed company, which dates back to 1903. More than ever, Xellia will focus on the continuous improvement of our service offering. 

Xellia has approximately 900 employees worldwide and has development and production sites in Denmark, Norway, Hungary and China. Learn more at

Number of employees: 420
Number of employees world wide: 900
Sector: Bioteknologi & Medico